Nurix Therapeutics, Inc. (NRIX) earnings date
Feb 4, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 39 days, typically, give or take 9 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Oct 13, 2026 | before open | 43 | 8-K |
| Q2 FY2026 | Thu, Jul 9, 2026 | after close | 39 | 8-K |
| Q1 FY2026 | Wed, Apr 8, 2026 | before open | 39 | 8-K |
| Q4 FY2025 | Wed, Jan 28, 2026 | after close | 59 | 8-K |
| Q3 FY2025 | Thu, Oct 9, 2025 | after close | 39 | 8-K |
| Q2 FY2025 | Wed, Jul 9, 2025 | after close | 39 | 8-K |
| Q1 FY2025 | Tue, Apr 8, 2025 | after close | 39 | 8-K |
| Q4 FY2024 | Tue, Jan 28, 2025 | after close | 59 | 8-K |
What they guided beta
| Q3 FY2026 | "Such risks and uncertainties include, but are not limited to: (i) whether Nurix and its collaborators will be able to advance drug candidates, obtain regulatory approval and ultimately commercialize drug candidates; (ii) uncertainties related to the timing and results of preclinical studies and clinical trials; (iii) the unexpected emergence of adverse events or other undesirable side effects during clinical development; (iv) whether Nurix will be able to fund development activities and achieve development goals, including its obligations under the Nurix-Roche collaboration; (v) uncertainties " exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 [Nurix logo] Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co-commercialization collaboration includes comprehensive clinical development plan in malignant hematology and enables expansion of bexobrutideg into chronic spontaneous urticaria (CSU) and multiple sclerosis (MS) Presented clinical data update at the European Hematology Association (EHA) supporti" exhibit |
| Q2 FY2026 | "In the second fiscal quarter of 2026, Nurix earned a $2 million milestone payment from Sanofi. * Expected timing of events throughout this press release is based on calendar year quarters." exhibit |
| Q2 FY2026 | "In addition, we expect to receive the $700 million upfront payment from Roche in the third fiscal quarter of 2026." exhibit |
| Q2 FY2026 | "Such risks and uncertainties include, but are not limited to: (i) whether Nurix will be able to advance its drug candidates, obtain regulatory approval of and ultimately commercialize its drug candidates; (ii) uncertainties related to the timing and results of preclinical studies and clinical trials; (iii) whether Nurix will be able to fund development activities and achieve development goals; (iv) uncertainties related to the timing and receipt of payments from Nurix’s collaboration partners, including milestone payments and royalties on future product sales; (v) the impact of global business" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/NRIX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/NRIX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/NRIX/"><img src="https://veritasdata.dev/embed/NRIX.svg" alt="NRIX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/NRIX/)
Script
<script async src="https://veritasdata.dev/embed/NRIX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/NRIX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.